8 Additional Assays for The Bayer Advia 1650 Chemistry System
Apolipoproteins. 510(k) K992662, from Bayer Corp. (Tarrytown, NY). Product code MSJ, class 1.
As of Nov 21, 2026, K992662 is an FDA 510(k) held by Bayer Corp., substantially equivalent on Feb 15, 2000 after 190 days, with 1 recall tied to it in FDA's recall database.
- Review time: 190 days
- Recalls: 1
- Cited as a predicate by: 1 device
The Bayer ADVIA 1650 Apolipoprotein A-1 (APO-A) assay is an in vitro diagnostic method intended to measure Apolipoprotein A-1 concentration in human serum and plasma on an Advia 1650 Chemistry System. Measurements are used to aid in the assessment of risk for arteriosclerosis and coronary artery disease.
- Advia Chemistry C-Reactive Protein_2, (CRP_2) and CalibratorsK072658 · Siemens Medical Solutions Diagnostics · Apr 1, 2008
| Started | Recall | Status |
|---|---|---|
| Dec 15, 2023 | Z-1003-2024Potential for a negative bias with quality control (QC) and patient sample results when using the Atellica CH Immunoglobulin M_2 (IgM_2) reagent. | Open |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 9, 1999
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1475
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files